Evidence map›Paper›PMID 39698378›Full record

ArticleAdvances in hematology2024

Early Molecular Response to Imatinib First-Line Therapy and Predictive Factors of Poor Outcomes for Chronic Myeloid Leukemia Patients in Côte d'Ivoire.

Kouassi Gustave Koffi, Sara Akou Bognini, Dohoma Alexis Silué, Ismael Kamara, Ines Kouakou, Emeraude N'dhatz, Boidy Kouakou, Danho Clotaire Nanho, David Tea Okou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kouassi Gustave KoffiDepartment of Hematology Teaching Hospital, Centre Hospitalier Universitaire de Yopougon, 21 BP 632, Abidjan 21, Ivory Coast.ORCID https://orcid.org/0009-0002-3994-5207
Sara Akou BogniniDepartment of Hematology Teaching Hospital, Centre Hospitalier Universitaire de Yopougon, 21 BP 632, Abidjan 21, Ivory Coast.
Dohoma Alexis SiluéDepartment of Hematology Teaching Hospital, Centre Hospitalier Universitaire de Yopougon, 21 BP 632, Abidjan 21, Ivory Coast.
Ismael KamaraDepartment of Hematology Teaching Hospital, Centre Hospitalier Universitaire de Yopougon, 21 BP 632, Abidjan 21, Ivory Coast.
Ines KouakouDepartment of Hematology Teaching Hospital, Centre Hospitalier Universitaire de Yopougon, 21 BP 632, Abidjan 21, Ivory Coast.
Emeraude N'dhatzDepartment of Hematology Teaching Hospital, Centre Hospitalier Universitaire de Yopougon, 21 BP 632, Abidjan 21, Ivory Coast.
Boidy KouakouDepartment of Hematology Teaching Hospital, Centre Hospitalier Universitaire de Yopougon, 21 BP 632, Abidjan 21, Ivory Coast.
Danho Clotaire NanhoDepartment of Hematology Teaching Hospital, Centre Hospitalier Universitaire de Yopougon, 21 BP 632, Abidjan 21, Ivory Coast.
David Tea OkouDepartment of Genetics, Clinic Saint George, Abidjan, Ivory Coast.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Africachronic myeloid leukemiaimatinibmolecular response

Identifiers

PMID39698378
PMCPMC11655142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.